Skip to content

Formoterol

Formoterol (Dulera) is used with a controller medicine for asthma and to prevent bronchospasm. This catalogue includes two inhalers, Foracort Inhaler and Dulera, in the same respiratory category.

Foracort Inhaler

Asthma, Chronic Obstructive Pulmonary Disease

100mcg + 6mcg · 200mcg + 6mcg · 400mcg + 6mcg

Formoterol and budesonide inhaler for asthma and COPD. The budesonide reduces swelling while formoterol opens the airways.

From$40.40/ inhalerView

Dulera

Asthma, Chronic Obstructive Pulmonary Disease

6mсg + 200mсg

Mometasone and formoterol inhaler for asthma and COPD. It combines a steroid and a long-acting bronchodilator.

From$68.17/ inhalerView

Key points

  • Asthma-related death: Long-acting beta2-agonists such as formoterol increase this risk; the label treats it as a class effect.
  • Controller medicine: Formoterol must not be used for asthma without a long-term control medicine, such as an inhaled corticosteroid.
  • What remains uncertain: Available data cannot determine whether an inhaled corticosteroid reduces the LABA-related asthma-death risk.

Brands and forms in this catalogue

Both listed inhalers pair formoterol, a long-acting beta2-agonist (LABA), with a corticosteroid. Foracort Inhaler contains budesonide, while Dulera contains mometasone furoate. They are listed for Asthma and Chronic Obstructive Pulmonary Disease, within Respiratory Health.

Further reading